Characterization of branched poly(lactide-co-glycolide) polymers used in injectable, long-acting formulations.


Journal

Journal of controlled release : official journal of the Controlled Release Society
ISSN: 1873-4995
Titre abrégé: J Control Release
Pays: Netherlands
ID NLM: 8607908

Informations de publication

Date de publication:
28 06 2019
Historique:
received: 16 03 2019
revised: 24 04 2019
accepted: 28 04 2019
pubmed: 6 5 2019
medline: 10 9 2020
entrez: 6 5 2019
Statut: ppublish

Résumé

Poly(lactide-co-glycolide) (PLGA) has been used in many injectable, long-acting depot formulations. Despite frequent use of PLGA, however, its characterization has been limited to measuring its molecular weight, lactide:glycolide (L:G) ratio, and end-group. These conventional methods are not adequate for characterization of unique PLGA polymers, such as branched PLGA. Glucose-initiated PLGA (Glu-PLGA) has been used in Sandostatin® LAR Depot (octreotide acetate for injectable suspension) approved by the U.S. Food and Drug Administration (FDA) in 1998. Glu-PLGA is a branched (also known as star-shaped) polymer and determining its properties has been challenging. It is necessary to develop methods that can determine and characterize the branching parameters of Glu-PLGA. Such characterization is important not only for the quality control of formulations, but also for developing generic parenteral formulations that are required to have the same excipients in the same amount (qualitative/quantitative (Q1/Q2) sameness) as their Reference Listed Drug (RLD). In this study, an analytical technique was developed and validated using a series of branched-PLGA standards, and it was used to determine the branching parameters of Glu-PLGA extracted from Sandostatin LAR, as well as Glu-PLGAs obtained from three different manufacturers. The analytical technique was based on gel-permeation-chromatography with quadruple detection systems (GPC-4D). GPC-4D enabled characterization of Glu-PLGA in its concentration, absolute molecular weight, hydrodynamic radius and intrinsic viscosity. The plot of the branch units per molecule as a function of molar mass provides a unique profile of each branched PLGA. The Mark-Houwink plots were also used to distinguish different Glu-PLGAs. These ensemble identification methods indicate that the branch units of Glu-PLGAs extracted from Sandostatin LAR range from 2 (i.e., linear) at the lower end of the molecular weight to <4 for the majority (94%) of Glu-PLGA.

Identifiants

pubmed: 31054992
pii: S0168-3659(19)30242-1
doi: 10.1016/j.jconrel.2019.04.039
pii:
doi:

Substances chimiques

Delayed-Action Preparations 0
Excipients 0
Polylactic Acid-Polyglycolic Acid Copolymer 1SIA8062RS
Glucose IY9XDZ35W2
Octreotide RWM8CCW8GP

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S. Validation Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

75-89

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Auteurs

Justin Hadar (J)

Akina, Inc., 3495 Kent Avenue, Suite A200, West Lafayette, IN 47906, USA.

Sarah Skidmore (S)

Akina, Inc., 3495 Kent Avenue, Suite A200, West Lafayette, IN 47906, USA.

John Garner (J)

Akina, Inc., 3495 Kent Avenue, Suite A200, West Lafayette, IN 47906, USA.

Haesun Park (H)

Akina, Inc., 3495 Kent Avenue, Suite A200, West Lafayette, IN 47906, USA.

Kinam Park (K)

Akina, Inc., 3495 Kent Avenue, Suite A200, West Lafayette, IN 47906, USA; Biomedical Engineering and Pharmaceutics, Purdue University, 206 S. Martin Jischke Drive, West Lafayette, IN 47907, USA. Electronic address: pk@akinainc.com.

Yan Wang (Y)

Food and Drug Administration, Center for Drug Evaluation and Research, Office of Generic Drugs, 10903 New Hampshire Avenue, Silver Spring, MD 20993, USA.

Bin Qin (B)

Food and Drug Administration, Center for Drug Evaluation and Research, Office of Generic Drugs, 10903 New Hampshire Avenue, Silver Spring, MD 20993, USA.

Xiaohui Jiang (X)

Food and Drug Administration, Center for Drug Evaluation and Research, Office of Generic Drugs, 10903 New Hampshire Avenue, Silver Spring, MD 20993, USA.

Articles similaires

Measurement of α-synuclein as protein cargo in plasma extracellular vesicles.

Tal Gilboa, Dmitry Ter-Ovanesyan, Shih-Chin Wang et al.
1.00
alpha-Synuclein Extracellular Vesicles Humans Phosphorylation Parkinson Disease

Metabolic engineering of

Jae Sung Cho, Zi Wei Luo, Cheon Woo Moon et al.
1.00
Corynebacterium glutamicum Metabolic Engineering Dicarboxylic Acids Pyridines Pyrones

Glucose and glutamine drive hepatitis E virus replication.

Shaheen Khan, Suruchi Aggarwal, Pooja Bhatia et al.
1.00
Glutamine Virus Replication Hepatitis E virus Glucose Glycolysis

Classifications MeSH